In this new study Associate Professor of Sociology Shai Mulinari, has together with Andreas Vilhelmsson, Emily Rickard and Piotr Ozieranski, analyzed financial support from pharmaceutical companies to patient organisations in Sweden between 2014 and 2018. They have also investigated possible commercial motives behind the financing.
The study reveals close and widespread ties between patient organisations and drug companies. Relatively few companies dominated the funding landscape by supporting patient organisations in disease areas linked to their drug portfolios.
This commercially motivated funding may contribute to inequalities in resource and influence between patient organisations. The association between drug commercialisation and industry funding is also worrying because of the therapeutic uncertainty of many new drugs.
Learn more about Shai Mulinari’s research on soc.lu.se/en/shai-mulinari
